Liver fat measurement study using ultrasound and MRI
Part of Digestive system, Hormones & metabolism clinical trials.
This trial compares a new ultrasound technique to a standard MRI scan for measuring liver fat. It may help improve how we diagnose and monitor fatty liver disease.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with or are suspected to have fatty liver disease.
- You have conditions like obesity, type 2 diabetes, or abnormal cholesterol levels.
- Your doctor has already recommended an upper abdominal ultrasound as part of your care.
- You cannot have metal implants, a pacemaker, or be pregnant (for MRI safety).
- You do not drink more than 2 drinks per day (for women) or 3 drinks per day (for men).
- You do not have hepatitis B, C, or other serious liver diseases.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is testing a new ultrasound method to measure fat in the liver. It is for people who may have a liver condition or have risk factors like diabetes or obesity, as well as healthy volunteers.
This study compares ultrasound (DeepUSFF) and MRI (MRI-PDFF) for measuring liver fat in people with MASLD (a type of fatty liver disease not caused by alcohol). It aims to see if ultrasound can be used as a cheaper, more accessible alternative to MRI.
This study uses ultrasound to look at the liver and help classify a type of fatty liver disease called MASLD. It may help doctors better understand and diagnose this condition.
This study tests a new ultrasound device that uses sound waves to measure fat in the liver without needles or surgery. It is for people with a type of fatty liver disease called MASLD or MASH, who are already getting an MRI to check their liver.
This study uses a new MRI technique to measure how metabolic fatty liver disease affects your body and to track your health over time. It aims to improve understanding of the condition and guide treatment.
This study tests whether a new type of MRI scan can better detect and measure liver disease, including fatty liver and scarring, compared to standard CT scans. If you have chronic liver disease, this study may help improve how we diagnose and track it.
Hear when a new Metabolic Dysfunction-Associated Liver Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.